Sign In
Buy ICLR
$142.67
+1.94 (+1.38%)
At Close: Jun 23, 2026
ICLR vs. DOCS: Which Stock Is the Better Value Option?
12:41pm, Thursday, 14'th Mar 2024
Investors with an interest in Medical Services stocks have likely encountered both Icon PLC (ICLR) and Doximity (DOCS). But which of these two companies is the best option for those looking for underv
3 Medical Services Stocks to Buy as Industry Trends Improve
12:51pm, Wednesday, 13'th Mar 2024
The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and ICLR are set to gain the most.
ICON (ICLR) Gains From Strategic Deals, New Innovations
12:30pm, Monday, 04'th Mar 2024
ICON (ICLR) continues to evolve its collaboration and delivery models, invest in technology, and enhance its project and program management capabilities.
Are You Looking for a Top Momentum Pick? Why Icon PLC (ICLR) is a Great Choice
01:01pm, Thursday, 29'th Feb 2024
Does Icon PLC (ICLR) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About Icon PLC (ICLR) Rating Upgrade to Buy
01:01pm, Wednesday, 28'th Feb 2024
Icon PLC (ICLR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Momentum in Icon PLC (ICLR) Should Keep going
09:51am, Wednesday, 28'th Feb 2024
Icon PLC (ICLR) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our s
ICON plc to Present at Upcoming Investor Conferences
04:15pm, Monday, 26'th Feb 2024
DUBLIN--(BUSINESS WIRE)--ICON plc to Present at Upcoming Investor Conferences.
ICON (ICLR) Q4 Earnings Surpass Estimates, Margins Expand
05:36pm, Thursday, 22'nd Feb 2024
ICON's (ICLR) solid performance in the fourth quarter reflects continued market leadership across customer segments it serves.
Icon PLC (ICLR) Q4 Earnings Surpass Estimates
07:30pm, Wednesday, 21'st Feb 2024
Icon PLC (ICLR) came out with quarterly earnings of $3.46 per share, beating the Zacks Consensus Estimate of $3.44 per share. This compares to earnings of $3.13 per share a year ago.
ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
11:07pm, Wednesday, 31'st Jan 2024
ICON Public is a global clinical research organization that provides services for the pharmaceutical, biotechnology, and medical device industries. The clinical research organization sector is expecte
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
06:00am, Tuesday, 30'th Jan 2024
DUBLIN--(BUSINESS WIRE)--ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call.
ICON: Starting Valuations And Business Returns Are 2 Major Hurdles
10:14pm, Sunday, 26'th Nov 2023
The market's response after ICON's Q3 numbers indicates it is forecasting a period of better business for the company in 2024. ICLR's projected earnings growth out to 2025 is 9-14% on sales growth of
3 Reasons Growth Investors Will Love Icon PLC (ICLR)
02:17pm, Monday, 20'th Nov 2023
Icon PLC (ICLR) could produce exceptional returns because of its solid growth attributes.
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners
10:00am, Tuesday, 14'th Nov 2023
Nvidia is leading the artificial intelligence revolution, and that's not likely to change. The world will always need new drugs, and Icon can help bring them to market.
ICLR or DOCS: Which Is the Better Value Stock Right Now?
12:47pm, Friday, 10'th Nov 2023
Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or Doximity (DOCS). But which of these two stocks offers value investors a better bang for the
